Yulia Maxuitenko

A Novel Sulindac Derivative That Does Not Inhibit Cyclooxygenases but Potently Inhibits Colon Tumor Cell Growth and Induces Apoptosis with Antitumor Activity

Gary A. Piazza, Adam B. Keeton, Heather N. Tinsley et al. · Cancer Prevention Research · 2009 · 97 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Transient intervention with oltipraz protects against aflatoxin-induced hepatic tumorigenesis.

M.G. Bolton, Álvaro Muñoz, Lisa P. Jacobson et al. · PubMed · 1993 · 96 citations

Pharmacy, Pharmacology, Toxicology +15

Colon Tumor Cell Growth–Inhibitory Activity of Sulindac Sulfide and Other Nonsteroidal Anti-Inflammatory Drugs Is Associated with Phosphodiesterase 5 Inhibition

Heather N. Tinsley, Bernard D. Gary, Jose Thaiparambil et al. · Cancer Prevention Research · 2010 · 93 citations · Full text

Medicine, Oncology, Pharmacology +13

Sorafenib is efficacious and tolerated in combination with cytotoxic or cytostatic agents in preclinical models of human non-small cell lung carcinoma

Christopher A. Carter, Charles Chen, Cheryl Brink et al. · Cancer Chemotherapy and Pharmacology · 2006 · 87 citations

Medicine, Oncology, Pharmacology +10

Identification of dithiolethiones with better chemopreventive properties than oltipraz

Yulia Maxuitenko · Carcinogenesis · 1998 · 72 citations · Full text

Medicine, Pharmacology, Toxicology +17